“Numerous clinical studies—including peer-reviewed randomized controlled trials—showed large magnitude benefits of ivermectin in prophylaxis, early treatment, and also in late-stage disease management. Taken together . . . dozens of clinical trials that have now emerged from around the world are substantial enough to reliably assess clinical efficacy and infer a signal of benefit with acceptable safety.”
